Ireland
--:--IST
Recruiting Observational

Prevalence of Amyloidosis in Trauma Patients

NCT06527521 · tracked via the Priya Life Science Spain tracker
Phase
Observational
Started
2024-11-13
Last updated
2025-12-02

Condition(s) studied

Amyloidosis

Investigational drug(s) / intervention(s)

Traumatologic surgery

Traumatologic surgery: Patients undergoing trauma surgery

Study summary

This study aims to determine the frequency of amyloidosis among patients undergoing trauma surgery.

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Men and women included in the waiting list for scheduled trauma surgery with at least one of the following criteria defined as red flags: Over 65 years old; Possible family history of amyloidosis, Cardiac pathology: aortic stenosis, presence of left ventricular hypertrophy defined as interventricular septal thickness \> 12mm measured by echocardiography, history of previous brady- or tachyarrhythmias including cardiac conduction blocks, history of syncope or presyncope, pro BNP \> 300 in previous blood tests; History of sensory peripheral neuropathy; History of nephropathy without etiological diagnosis; History of liver disease without a clear cause. * Ability to cooperate in the necessary evaluations. * Signed informed consent for inclusion in the study, either by the participant or their legal representative. Exclusion Criteria: \- Participants previously diagnosed with amyloidosis cannot be included in the study.

Primary outcome measure(s)

  • Amyloidosis — One month
    Proportion of patients undergoing scheduled orthopedic surgery who are diagnosed with amyloidosis.

Trial sites (1)

FacilityCityRegionStatus
Consorci Sanitari Alt Penedes i Garraf-Hospital Sant Camil Sant Pere de Ribes Barcelona Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06527521 on ClinicalTrials.gov ↗ ← All trials in Spain